Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Data from animal studies suggests that glutamine supplementation may reduce the incidence or severity of cytotoxic-induced mucositis. This study examined the effect of glutamine supplements on mucositis in patients receiving bone marrow transplants. 24 patients were randomly assigned to receive an oral supplement of either glutamine or placebo (16 g/day) from the time of transplantation until discharge from hospital. There was no significant difference in the incidence of oral mucositis, assessed either by the patient (mucositis score: glutamine 17 vs. placebo 26.6) or an independent observer (glutamine 31.1 vs. placebo 32.3), or the number of days of diarrhoea (glutamine 3.1 vs. placebo 3.3 days). Similarly there were no significant differences in haematological indices (haemoglobin, WBC, platelets), the requirement for parenteral nutrition or hospital stay. Possible reasons for this negative result, which contrasts with those obtained in recent studies of patients receiving intravenous glutamine after bone marrow transplants, are discussed.

Type

Journal article

Journal

Clin Nutr

Publication Date

06/1995

Volume

14

Pages

162 - 165